D.E. Shaw & Co’s Nu Skin NUS Stock Holding History

D.E. Shaw & Co’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-50,000	Closed	-$692K	–	4738
2024 Q1	$692K	Buy	+50,000	New	+$781K	﹤0.01%	3317
2018 Q1	–	Sell	-13,300	Closed	-$907K	–	3697
2017 Q4	$907K	Hold	13,300	–	–	﹤0.01%	2636
2017 Q3	$818K	Hold	13,300	–	–	﹤0.01%	2622
2017 Q2	$836K	Hold	13,300	–	–	﹤0.01%	2524
2017 Q1	$739K	Hold	13,300	–	–	﹤0.01%	2507
2016 Q4	$635K	Buy	13,300 +3,300	+33%	+$185K	﹤0.01%	2722
2016 Q3	$648K	Buy	+10,000	New	+$562K	﹤0.01%	2648
2015 Q1	–	Sell	-132,200	Closed	-$5.78M	–	3885
2014 Q4	$5.78M	Buy	132,200 +40,000	+43%	+$1.77M	0.01%	1458
2014 Q3	$4.15M	Hold	92,200	–	–	0.01%	1694
2014 Q2	$6.82M	Hold	92,200	–	–	0.01%	1381
2014 Q1	$7.64M	Sell	92,200 -26,900	-23%	-$2.36M	0.01%	1245
2013 Q4	$16.5M	Buy	119,100 +35,400	+42%	+$4.17M	0.02%	805
2013 Q3	$8.01M	Buy	83,700 +58,300	+230%	+$4.95M	0.01%	1199
2013 Q2	$1.55M	Buy	+25,400	New	+$1.41M	﹤0.01%	2356

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

D.E. Shaw & Co's NUS Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Nu Skin (NUS) stake by 33% in Q1 2026, selling an estimated $1.95M and leaving 444,086 shares worth $3.23M. The position accounts for ﹤0.01% of the portfolio, ranked #2523.

D.E. Shaw & Co first reported a position in NUS in Q2 2013 and has held it in 37 quarters since. The position peaked at $59.8M in Q2 2019. 178 funds tracked by Wall St. Rank hold NUS as of Q1 2026.

D.E. Shaw & Co held 444,086 shares of Nu Skin worth $3.23M as of Q1 2026.
D.E. Shaw & Co sold 215,176 Nu Skin shares in Q1 2026, an estimated $1.95M.
Nu Skin made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2523 holding.
D.E. Shaw & Co first reported a position in Nu Skin in Q2 2013 and has held it in 37 quarters since.
D.E. Shaw & Co's Nu Skin position peaked at $59.8M in Q2 2019.
178 funds tracked by Wall St. Rank held Nu Skin as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.